Dennis Leo Walsh - Net Worth and Insider Trading
Dennis Leo Walsh Net Worth
The estimated net worth of Dennis Leo Walsh is at least $280,060 dollars as of 2024-05-20. Dennis Leo Walsh is the Director of Deciphera Pharmaceuticals Inc and owns about 11,000 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $280,060. Details can be seen in Dennis Leo Walsh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dennis Leo Walsh has not made any transactions after 2023-05-10 and currently still holds the listed stock(s).
Transaction Summary of Dennis Leo Walsh
Dennis Leo Walsh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dennis Leo Walsh owns 1 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) .
Click here to see the complete history of Dennis Leo Walsh’s form 4 insider trades.
Insider Ownership Summary of Dennis Leo Walsh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2023-05-10 | director |
Dennis Leo Walsh Latest Holdings Summary
Dennis Leo Walsh currently owns a total of 1 stock. Dennis Leo Walsh owns 11,000 shares of Deciphera Pharmaceuticals Inc (DCPH) as of May 10, 2023, with a value of $280,060.
Latest Holdings of Dennis Leo Walsh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2023-05-10 | 11,000 | 25.46 | 280,060 |
Holding Weightings of Dennis Leo Walsh
Dennis Leo Walsh Form 4 Trading Tracker
According to the SEC Form 4 filings, Dennis Leo Walsh has made a total of 1 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the acquisition of 11,000 shares on May 10, 2023, which cost Dennis Leo Walsh around $152,460.
Insider Trading History of Dennis Leo Walsh
- 1
Dennis Leo Walsh Trading Performance
GuruFocus tracks the stock performance after each of Dennis Leo Walsh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dennis Leo Walsh is 11.34%. GuruFocus also compares Dennis Leo Walsh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dennis Leo Walsh within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dennis Leo Walsh's insider trading performs compared to the benchmark.
Performance of Dennis Leo Walsh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.89 | | | | | |
| Relative Return to S&P 500(%) | -2.01 | | | | | |
Dennis Leo Walsh Ownership Network
Dennis Leo Walsh Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
Dennis Leo Walsh is the director of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include SVP & Regulatory & Quality Jama Pitman , Chief Commercial Officer Daniel C. Martin , and Chief Financial Officer Thomas Patrick Kelly .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, Dennis Leo Walsh made 1 insider transaction in Deciphera Pharmaceuticals Inc (DCPH) with a net purchase of 11,000. Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 26,559 shares made by Daniel C. Martin , a net sale of 14,587 shares made by Matthew L Sherman , and a net sale of 11,601 shares made by Thomas Patrick Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 154,121 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 1,687,666 shares were bought by its insiders, resulting in a net purchase of 1,533,545 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
Dennis Leo Walsh Mailing Address
Above is the net worth, insider trading, and ownership report for Dennis Leo Walsh. You might contact Dennis Leo Walsh via mailing address: C/o Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
